Apellis Pharmaceuticals has recalled approximately 61,943 Apellis Injection Kits (Reference IVT-KIT-29G) because the 19-gauge filter needles included in the kits may have structural variations or non-preferred characteristics. These structural issues have been associated with rare reports of retinal vasculitis, a serious condition involving inflammation of the eye's blood vessels, although a direct causal link has not yet been confirmed. The kits were distributed nationwide across the United States. Consumers and healthcare providers should immediately check their supplies for the specific lot numbers affected by this recall.
Structural defects in the filter needles could potentially lead to retinal vasculitis during medical procedures, which may cause eye inflammation and threaten a patient's vision.
Manufacturer contact for instructions.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.